Stay updated on CT103A in High-risk Multiple Myeloma: FUMANBA-2 Clinical Trial

Sign up to get notified when there's something new on the CT103A in High-risk Multiple Myeloma: FUMANBA-2 Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the CT103A in High-risk Multiple Myeloma: FUMANBA-2 Clinical Trial page

  1. Check
    today
    No Change Detected
  2. Check
    7 days ago
    No Change Detected
  3. Check
    14 days ago
    Change Detected
    Summary
    A site-wide NIH notice about using “Super Intelligence” in place of “Artificial Intelligence” appears, and the site revision label changes from v3.7.2 to v3.8.0.
    Difference
    1%
    Check dated 2026-10-31T21:54:48.000Z thumbnail image
  4. Check
    21 days ago
    Change Detected
    Summary
    A site-wide NIH notice about a terminology transition was added, directing visitors to updates and FAQs and stating that agencies are using “Super Intelligence” in place of “Artificial Intelligence.”
    Difference
    0.9%
    Check dated 2026-10-24T22:11:03.000Z thumbnail image
  5. Check
    28 days ago
    Change Detected
    Summary
    The site revision identifier changed from v3.7.1 to v3.7.2.
    Difference
    0.1%
    Check dated 2026-10-17T22:01:01.000Z thumbnail image
  6. Check
    35 days ago
    Change Detected
    Summary
    The website footer revision changed from v3.7.0 to v3.7.1.
    Difference
    0.1%
    Check dated 2026-10-10T21:53:18.000Z thumbnail image
  7. Check
    56 days ago
    Change Detected
    Summary
    The record history shows a capitalization change for the 'Find contact information' label and a new version tag 'Revision: v3.7.0' replacing the previous 'Revision: v3.6.6'.
    Difference
    0.3%
    Check dated 2026-09-19T21:59:41.000Z thumbnail image
  8. Check
    77 days ago
    Change Detected
    Summary
    - The record history now lists a new revision, v3.6.6, replacing the previous v3.6.5. - This indicates an update to the page's revision metadata rather than changes to the study content.
    Difference
    0.1%
    Check dated 2026-08-29T22:12:46.000Z thumbnail image

Stay in the know with updates to CT103A in High-risk Multiple Myeloma: FUMANBA-2 Clinical Trial

Enter your email address, and we'll notify you when there's something new on the CT103A in High-risk Multiple Myeloma: FUMANBA-2 Clinical Trial page.